E.01REFUTES
Insulin Discovery
Frederick Banting and Charles Best isolated insulin in 1921. First human treatment in 1922 — a century before TikTok existed.
PEPTIDE MYTHBUSTER
When a century of medicine meets social media skepticism
Verdict:BUSTED
PEPTIDES ARE JUST A TREND
Myth #004 / Analysis
01 / The Claim
WHAT PEOPLE SAY
"Peptides are just another wellness fad being pushed by influencers — they'll disappear like every other internet health trend.
02 / Evidence
THE DATA
Each point of evidence assessed against the original claim.
E.02REFUTES
FDA Approvals
Over 80 peptide drugs have received FDA approval. Another 150+ are in active clinical trials.
E.03REFUTES
Market Reality
Peptide therapeutics generate $15-20 billion annually. Trends don't sustain multi-billion dollar pharmaceutical pipelines.
E.04REFUTES
Semaglutide Success
GLP-1 peptides like semaglutide became the most prescribed diabetes and obesity treatments in history. Clinical efficacy, not marketing.
E.05NEUTRAL
Social Visibility
Recent social media attention has increased public awareness. Visibility isn't the same as validity — but it's not nothing.
E.06SUPPORTS
Quality Concerns
Influencer promotion has driven demand for unregulated peptide sources. This is a legitimate concern worth acknowledging.
03 / Verdict
THE RULING
Peptide therapeutics have been saving lives since 1922. Insulin alone predates influencers by about 80 years.
04 / Key Facts
THE SCIENCE
1922 FIRST USE
Insulin was first administered to a human patient over 100 years ago. Leonard Thompson, age 14, survived.
80+ APPROVED
The FDA has approved more than 80 peptide-based drugs. They treat diabetes, cancer, osteoporosis, and HIV.
$50B MARKET
Global peptide therapeutics market exceeds $50 billion. Projected to double within the decade.
CENTURY OF USE
Peptide medicine spans from 1922 insulin to 2024 tirzepatide. That's not a trend — it's an entire field.
05 / Deep Dive
WHY IT MATTERS
The conflation of peptide therapeutics with influencer culture ignores a century of medical history. Insulin, the first commercially available peptide drug, transformed Type 1 diabetes from a death sentence into a manageable condition. Today, over 80 FDA-approved peptide drugs treat conditions from cancer to metabolic disorders, generating billions in annual revenue.
06 / Sources
REFERENCES
- [01]
Muttenthaler M, King GF, Adams DJ, Alewood PF (2021). Trends in peptide drug discovery. Nature Reviews Drug Discovery.
View Source - [02]
Lau JL, Dunn MK (2018). Therapeutic peptides: Historical perspectives, current development trends, and future directions. Bioorganic & Medicinal Chemistry.
View Source - [03]
Blundell TL, Cutfield JF, Cutfield SM, et al. (1971). Atomic positions in rhombohedral 2-zinc insulin crystals. Nature.
View Source - [04]
Drucker DJ (2018). Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1. Cell Metabolism.
View Source
insulinFDA-approvedmedical-historytherapeuticssemaglutide
Peptide Mythbuster. Evidence-based analysis.
Back to All Myths